With a market cap of $85.2 billion, Elevance Health, Inc. (ELV) is a health benefits company, offering a wide range of medical, pharmacy, and healthcare services across its four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It provides health plans, specialty insurance, pharmacy solutions, and healthcare management services under brands such as Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon.
The Indianapolis, Indiana-based company is expected to release its fiscal Q3 2026 results soon. Ahead of this event, analysts expect ELV to report an djusted EPS of $4.72, down 21.7% from $6.03 in the prior year's quarter. However, it has surpassed Wall Street's bottom-line estimates in each of the past four quarters.